✦ LIBER ✦

Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysis

✍ Scribed by C.A. Stringer; D.M. Gershenson; T.W. Burke; C.L. Edwards; A.N. Gordon; J.T. Wharton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy with cisplatin, do

✍ CA Stringer; DM Gershenson; TW Burke; CL Edwards; AN Gordon; JT Wharton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Postoperative Adjuvant Cisplatin, Doxoru

✍ Thomas W. Burke; David M. Gershenson; Mitchell Morris; C.Allen Stringer; Charles 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Postoperative adjuvant chemotherapy with

✍ Hideaki Yahata; Toshio Hirakawa; Takuji Fujita; Kazuya Ariyoshi; Kenzo Sonoda; S 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 212 KB

Early-stage high-risk endometrial cancer

✍ S. Schuman; J. Stine; W. Zhao; P. Yali; A. Wolfson; J. Lucci 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Final analysis of RTOG 9708: Adjuvant po

✍ Kathryn Greven; Kathryn Winter; Kelly Underhill; Jim Fontenesci; Jay Cooper; Tom 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 113 KB

P180 A cost effectiveness analysis of ad

✍ B.L. Rapoport; S.D. Moodley; C. Jacobs; R. Pienaar; S. Fourie; W.M. Szpak 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB